Mupina (Mupirocin)

Mupirocin blocks the bacterial enzyme isoleucyl‑tRNA synthetase, which is essential for protein synthesis. By preventing the incorporation of isoleucine into bacterial proteins, it halts bacterial growth and can kill the organism at higher concentrations.

The specific dose and duration of Mupina are determined by the prescribing healthcare professional based on the patient’s condition, age, and clinical guidelines. Patients should follow the prescriber’s instructions exactly and not alter the regimen on their own.

Mupirocin’s pregnancy safety category is listed as unknown. Use during pregnancy or lactation should only occur when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Mupina, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mupirocin is a topical antibiotic with high activity against Staphylococcus aureus, including MRSA, whereas alternatives such as povidone‑iodine or fusidic acid have broader antiseptic properties but may be less specific for resistant strains. Mupirocin’s targeted mechanism often results in more reliable eradication of S. aureus carriers.

Mupina should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Mupina is applied intranasally. The prescribed amount is usually placed into each nostril using a sterile applicator or cotton swab, following the dosing schedule provided by the prescriber. No oral ingestion is involved.

The most serious adverse reactions include allergic contact dermatitis, anaphylaxis (a rare systemic hypersensitivity), and secondary bacterial or fungal superinfection due to disruption of normal nasal flora. Patients should seek immediate medical attention if they experience severe rash, swelling, difficulty breathing, or signs of infection.

Mupina should be avoided in individuals with a known hypersensitivity to mupirocin or any component of the formulation. It is also contraindicated in patients where nasal decolonization is not indicated, and it should be used with caution in children, pregnant or lactating women until safety is confirmed by a healthcare professional.